Aethelfrith

I'm interviewing for an enzymologist position at a pharma company. So the keys here are models of inhibition and assay design. Although I have some experience setting up kinetics assays, it was in a different context and with little/no support or criticism from anyone in my company. My questions are: When would one choose an endpoint assay over a continuous/real time one? In a kinase assay, what are some ADvantages of measuring ADP over the phosphorylated substrate? When would you choose a linearized plot (eg Lineweaver Burke, Eadie Hofstee) over a non linear plot? How would dose-response data on a semi-log vs. linear scale look? Thanks in advance.